140 related articles for article (PubMed ID: 36421781)
1. Excavation of Molecular Subtypes of Endometrial Cancer Based on DNA Methylation.
Liu Y; Gu Y; Zhang M; Zeng J; Wang Y; Wang H; Liu X; Liu S; Wang Z; Wang Y; Wang L; Zhang Y
Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36421781
[TBL] [Abstract][Full Text] [Related]
2. Specific breast cancer prognosis-subtype distinctions based on DNA methylation patterns.
Zhang S; Wang Y; Gu Y; Zhu J; Ci C; Guo Z; Chen C; Wei Y; Lv W; Liu H; Zhang D; Zhang Y
Mol Oncol; 2018 Jun; 12(7):1047-1060. PubMed ID: 29675884
[TBL] [Abstract][Full Text] [Related]
3. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
[TBL] [Abstract][Full Text] [Related]
4. Prognostic evaluation of the novel blueprint of DNA methylation sites by integrating bulk RNA-sequencing and methylation modification data in endometrial cancer.
Zhou H; Zhang Y; Jin J; Shen K; Yang Y; Lao P
J Gene Med; 2024 Jan; 26(1):e3638. PubMed ID: 38011892
[TBL] [Abstract][Full Text] [Related]
5. Molecular subtypes based on DNA methylation predict prognosis in colon adenocarcinoma patients.
Yang C; Zhang Y; Xu X; Li W
Aging (Albany NY); 2019 Dec; 11(24):11880-11892. PubMed ID: 31852837
[TBL] [Abstract][Full Text] [Related]
6. Identification of endometrial cancer methylation features using combined methylation analysis methods.
Trimarchi MP; Yan P; Groden J; Bundschuh R; Goodfellow PJ
PLoS One; 2017; 12(3):e0173242. PubMed ID: 28278225
[TBL] [Abstract][Full Text] [Related]
7. Integrated Bioinformatic Analysis of DNA Methylation and Immune Infiltration in Endometrial Cancer.
Dai F; Wu J; Deng Z; Li H; Tan W; Yuan M; Yang D; Liu S; Zheng Y; Hu M; Yuan C; Cheng Y
Biomed Res Int; 2022; 2022():5119411. PubMed ID: 35774278
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation subtypes for ovarian cancer prognosis.
Yin L; Zhang N; Yang Q
FEBS Open Bio; 2021 Mar; 11(3):851-865. PubMed ID: 33278864
[TBL] [Abstract][Full Text] [Related]
9. Molecular subtypes based on DNA promoter methylation predict prognosis in lung adenocarcinoma patients.
Shi S; Xu M; Xi Y
Aging (Albany NY); 2020 Nov; 12(23):23917-23930. PubMed ID: 33237038
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation-based classification and identification of renal cell carcinoma prognosis-subgroups.
Chen W; Zhuang J; Wang PP; Jiang J; Lin C; Zeng P; Liang Y; Zhang X; Dai Y; Diao H
Cancer Cell Int; 2019; 19():185. PubMed ID: 31346320
[TBL] [Abstract][Full Text] [Related]
11. HDNA methylation data-based molecular subtype classification related to the prognosis of patients with hepatocellular carcinoma.
He H; Chen D; Cui S; Wu G; Piao H; Wang X; Ye P; Jin S
BMC Med Genomics; 2020 Aug; 13(1):118. PubMed ID: 32831081
[TBL] [Abstract][Full Text] [Related]
12. Exploration of DNA methylation markers for diagnosis and prognosis of patients with endometrial cancer.
Ying J; Xu T; Wang Q; Ye J; Lyu J
Epigenetics; 2018; 13(5):490-504. PubMed ID: 29912667
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation data-based prognosis-subtype distinctions in patients with esophageal carcinoma by bioinformatic studies.
Chen H; Qin Q; Xu Z; Chen T; Yao X; Xu B; Sun X
J Cell Physiol; 2021 Mar; 236(3):2126-2138. PubMed ID: 32830322
[TBL] [Abstract][Full Text] [Related]
14. Mining the Prognostic Role of DNA Methylation Heterogeneity in Lung Adenocarcinoma.
Liao H; Luo X; Huang Y; Yang X; Zheng Y; Qin X; Tan J; Shen P; Tian R; Cai W; Shi X; Deng X
Dis Markers; 2022; 2022():9389372. PubMed ID: 35677637
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer.
Mishra NK; Guda C
Oncotarget; 2017 Apr; 8(17):28990-29012. PubMed ID: 28423671
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide DNA methylation sequencing reveals miR-663a is a novel epimutation candidate in CIMP-high endometrial cancer.
Yanokura M; Banno K; Adachi M; Aoki D; Abe K
Int J Oncol; 2017 Jun; 50(6):1934-1946. PubMed ID: 28440489
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic changes as prognostic predictors in endometrial carcinomas.
Farkas SA; Sorbe BG; Nilsson TK
Epigenetics; 2017 Jan; 12(1):19-26. PubMed ID: 27874289
[TBL] [Abstract][Full Text] [Related]
18. Immune infiltration-related N6-methyladenosine RNA methylation regulators influence the malignancy and prognosis of endometrial cancer.
Ma J; Yang D; Ma XX
Aging (Albany NY); 2021 Jun; 13(12):16287-16315. PubMed ID: 34230220
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic fingerprint in endometrial carcinogenesis: the hypothesis of a uterine field cancerization.
Di Domenico M; Santoro A; Ricciardi C; Iaccarino M; Iaccarino S; Freda M; Feola A; Sanguedolce F; Losito S; Pasquali D; Di Spiezio Sardo A; Bifulco G; Nappi C; Bufo P; Guida M; De Rosa G; Abbruzzese A; Caraglia M; Pannone G
Cancer Biol Ther; 2011 Sep; 12(5):447-57. PubMed ID: 21709441
[TBL] [Abstract][Full Text] [Related]
20. Status and significance of CpG island methylator phenotype in endometrial cancer.
Zhang QY; Yi DQ; Zhou L; Zhang DH; Zhou TM
Gynecol Obstet Invest; 2011; 72(3):183-91. PubMed ID: 21968189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
